Literature DB >> 24568557

Efficacy of IVF following conservative management of endometrial cancer.

Diego Rossetti1, Giorgio Bogani, Marco Carnelli, Salvatore Giovanni Vitale, Giuseppe Grosso, Luigi Frigerio.   

Abstract

Five cases of conservative management of early stage uterine carcinoma were reported. All patients successfully underwent in vitro fertilization (IVF). Role of conservative treatment, IVF and prophylactic surgery followed competition of parity was discussed.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24568557     DOI： 10.3109/09513590.2014.892065

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN： 0951-3590            Impact factor:   2.260


  10 in total

Review 1.  Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?

Authors:  Gaetano Valenti; Salvatore Giovanni Vitale; Alessandro Tropea; Antonio Biondi; Antonio Simone Laganà
Journal:  Updates Surg       Date:  2017-09-16

2.  Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up.

Authors:  Pietro Cignini; Salvatore Giovanni Vitale; Antonio Simone Laganà; Antonio Biondi; Valentina Lucia La Rosa; Giuseppe Cutillo
Journal:  Updates Surg       Date:  2017-01-20

Review 3.  New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer.

Authors:  Diego Rossetti; Salvatore Giovanni Vitale; Alessandro Tropea; Antonio Biondi; Antonio Simone Laganà
Journal:  Updates Surg       Date:  2017-05-02

Review 4.  Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives.

Authors:  Salvatore Giovanni Vitale; Diego Rossetti; Alessandro Tropea; Antonio Biondi; Antonio Simone Laganà
Journal:  Updates Surg       Date:  2017-02-10

Review 5.  Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Stella Capriglione; Roberto Angioli; Valentina Lucia La Rosa; Salvatore Lopez; Gaetano Valenti; Fabrizio Sapia; Giuseppe Sarpietro; Salvatore Butticè; Carmelo Tuscano; Daniele Fanale; Alessandro Tropea; Diego Rossetti
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

6.  Psychological impact of fertility preservation techniques in women with gynaecological cancer.

Authors:  Antonio Simone Laganà; Valentina Lucia La Rosa; Agnese Maria Chiara Rapisarda; Alessio Platania; Salvatore Giovanni Vitale
Journal:  Ecancermedicalscience       Date:  2017-02-08

Review 7.  Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.

Authors:  Pierluigi Giampaolino; Valeria Cafasso; Dominga Boccia; Mario Ascione; Antonio Mercorio; Francesco Viciglione; Mario Palumbo; Paolo Serafino; Cira Buonfantino; Maria Chiara De Angelis; Paolo Verrazzo; Giovanna Grasso; Giuseppe Gullo; Giuseppe Bifulco; Luigi Della Corte
Journal:  Biomed Res Int       Date:  2022-09-27       Impact factor: 3.246

8.  The Importance of Fertility Preservation Counseling in Patients with Gynecologic Cancer.

Authors:  Salvatore Giovanni Vitale; Valentina Lucia La Rosa; Agnese Maria Chiara Rapisarda; Antonio Simone Laganà
Journal:  J Reprod Infertil       Date:  2017 Apr-Jun

Review 9.  Fertility preservation in endometrial cancer patients: options, challenges and perspectives.

Authors:  Milan Terzic; Melanie Norton; Sanja Terzic; Gauri Bapayeva; Gulzhanat Aimagambetova
Journal:  Ecancermedicalscience       Date:  2020-05-06

10.  Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.

Authors:  Francesca Falcone; Umberto Leone Roberti Maggiore; Violante Di Donato; Anna Myriam Perrone; Luigi Frigerio; Giuseppe Bifulco; Stephan Polterauer; Paolo Casadio; Gennaro Cormio; Valeria Masciullo; Mario Malzoni; Stefano Greggi
Journal:  J Gynecol Oncol       Date:  2020-09       Impact factor: 4.401
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.